| E-Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Diseases > An Aspirin A Day In Texas May Keep Cancer Away |
|
E-Articles - An Aspirin A Day In Texas May Keep Cancer Away
Individuals in Dallas, Houston and elsewhere in Texas who take an aspirin a day may lower the odds of colon, prostate and breast cancer if you are at high risk for those malignancies, researchers at the American Cancer According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product Society report. Men and women who used adult-strength aspirin daily for five or more years had about a 15 mepercent lower overall rate of developing cancer, particularly colon, prostate and possibly breast cancer, re ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in searchers reported. However, they also said that there's not enough evidence that aspirin's value as a cancer preventive outweighs its potential toxic side effects, which include a higher risk for bleeding. The Americ lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. an Cancer Society (ACS) didn't recommend using aspirin to prevent cancer, because aspirin has been known to cause serious gastrointestinal bleeding. In the study, researchers looked for a link between long-term use of here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe aspirin -- dosed at 325 milligrams or more a day -- and cancer in almost 70,000 men and more than 76,000 won participating in the Cancer Prevention Study II Nutrition Cohort. During twelve years of follow-up, more tha d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro n 18,000 men and women were diagnosed with cancer. The researchers found that the 15 percent relative reduction in overall cancer risk was not statistically significant for women, but it was associated with a 20 percen ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc t reduction in the risk of prostate cancer and a 30 percent reduction in the risk of colorectal cancer in both men and women, compared with people who didn't take the medicine. The ACS researchers noted that aspirin h easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ad no effect on the risks of lung cancer, bladder cancer, melanoma, leukemia, non-Hodgkin's lymphoma, pancreatic cancer, and kidney cancer. Also, aspirin use for less than five years did not lower the risk for cancer. nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically If more evidence comes to light suggesting that aspirin curbs cancer risk, the American Cancer Society said that its recommendations might someday change. Future recommendations could take cancer prevention into accou and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ nt when deciding on the best dose for people who already need to take aspirin for cardiovascular protection. But researchers said that they were not there yet. The Iowa Women's Health Study, published in 2006, found t ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi hat there may be an association between lung inflammation seen in asthma and increased risk of breast cancer spreading to the lungs. This study looked at more than 22,500 cancer-free postmenopausal women, recruited in ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a 1996. Ten years later, as reported, the researchers found that women who regularly used aspirin were 16 percent less likely to have developed cancer and 13 percent less likely to have died of cancer than women who did dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod not use aspirin. This same benefit was not seen in women who regularly used non-steroidal anti-inflammatory drugs (NSAIDs) other than aspirin, said another 2007 study by researchers at the Mayo Clinic in Rochester, Mi cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin nn.. This study suggests that reducing inflammation may help prevent cancer and it found that women who regularly used aspirin developed fewer cancers than women who didn't. And while aspirin helped protect former and tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen non smokers from cancer, this was not reported to be the case for women who were active smokers. The findings do not mean that women should not take NSAIDs or start taking aspirin on a regular basis, the Mayo Clinic t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel researchers said. "This is just one study. However, it does provide provocative evidence that regular aspirin use may play a role in preventing the most common chronic diseases in western countries, namely cancer and h ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust eart disease," Dr. Aditya Bardia, the lead author of the study said in a prepared statement. It's important to check with your physician before taking over-the-counter medicines, like aspirin, for a condition other th y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products an what they are designed for. How you treat your body when you’re young will certainly affect your health as you get older. Eventually, it will also affect your wallet. If you're a young individual who tries to stay . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de healthy, you should take a look at the revolutionary, comprehensive and highly affordable individual health insurance solutions created by Precedent specifically for you. For more information, visit us at our website, elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip www.precedent.com. We offer a unique and innovative suite of individual health insurance solutions, including highly competitive HSA-qualified plans and an unparalleled “real time" application and acceptance experience tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Opening a Dollar Store - Effective Merchandise Display Basics FOREX Trading - Catching The Big Trends Live Examples Computer Training - Building a PC, Piece By Piece
|